Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

317
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
317
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

464
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
464
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

682
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
682
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.5K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.5K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

340
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
340
Combinatorial Gene Control02:33

Combinatorial Gene Control

10.2K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peroxisome Proliferator-Activated Receptor (PPARγ) Plays a Protective Role in Cigarette Smoking-Induced Inflammation via AMP-Activated Protein Kinase (AMPK) Signaling.

Medical science monitor : international medical journal of experimental and clinical researchĀ·2018
Same author

Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data.

IEEE transactions on medical imagingĀ·2018
Same author

Superconductivity in FeSe: The Role of Nematic Order.

Physical review lettersĀ·2018
Same author

Suppressed expression of Cbl-b by NF-ĪŗB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.

Cell biology internationalĀ·2018
Same author

The independence of and associations among apoptosis, autophagy, and necrosis.

Signal transduction and targeted therapyĀ·2018
Same author

Tyrosine kinase inhibitor-induced IL-6/STAT3 activation decreases sensitivity of EGFR-mutant non-small cell lung cancer to icotinib.

Cell biology internationalĀ·2018

Related Experiment Video

Updated: Apr 12, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

A BAYESIAN NONPARAMETRIC MIXTURE MODEL FOR SELECTING GENES AND GENE SUBNETWORKS.

Yize Zhao1, Jian Kang1, Tianwei Yu1

  • 1Department of Biostatistics and Bioinformatics Emory University 1518 Clifton Rd. Atlanta, Georgia 30322 USA.

The Annals of Applied Statistics
|May 19, 2015
PubMed
Summary

Selecting informative genes from high-throughput data is challenging. This study introduces a novel nonparametric Bayesian model for gene selection using network information, improving upon existing regression models.

Keywords:
Dirichlet process mixturedensity estimationfeature selectionising priorsmicroarray data

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Related Experiment Videos

Last Updated: Apr 12, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • High-throughput data analysis presents challenges in selecting informative features from numerous measurements.
  • Existing gene selection methods often rely on parametric/regression models using gene network information.

Purpose of the Study:

  • To propose a novel nonparametric Bayesian model for gene selection that incorporates network information.
  • To identify genes strongly associated with clinical outcomes and those with unique expression patterns.
  • To address limitations of regression models in capturing specific gene expressional behaviors.

Main Methods:

  • Developed a nonparametric Bayesian model for gene selection integrating gene network information.
  • Demonstrated the model's equivalence to an infinite mixture model.
  • Implemented posterior computation using Markov chain Monte Carlo (MCMC) methods.
  • Proposed two efficient algorithms for approximating posterior simulations with reduced computational cost.

Main Results:

  • The proposed model effectively selects informative genes associated with clinical outcomes.
  • The model successfully identifies genes exhibiting particular expressional behaviors, which are often missed by regression models.
  • Simulation studies and analysis of yeast cell cycle microarray data validated the method's performance.

Conclusions:

  • The nonparametric Bayesian model offers a powerful alternative for gene selection in high-throughput data analysis.
  • The model's ability to capture diverse gene expressional patterns enhances its utility in biological research.
  • Efficient computational algorithms facilitate the practical application of this method.